1. Home
  2. VCEL vs CXW Comparison

VCEL vs CXW Comparison

Compare VCEL & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • CXW
  • Stock Information
  • Founded
  • VCEL 1989
  • CXW 1983
  • Country
  • VCEL United States
  • CXW United States
  • Employees
  • VCEL N/A
  • CXW N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • CXW Real Estate Investment Trusts
  • Sector
  • VCEL Health Care
  • CXW Real Estate
  • Exchange
  • VCEL Nasdaq
  • CXW Nasdaq
  • Market Cap
  • VCEL 2.0B
  • CXW 1.8B
  • IPO Year
  • VCEL 1997
  • CXW 1997
  • Fundamental
  • Price
  • VCEL $40.79
  • CXW $18.07
  • Analyst Decision
  • VCEL Strong Buy
  • CXW Strong Buy
  • Analyst Count
  • VCEL 6
  • CXW 2
  • Target Price
  • VCEL $60.40
  • CXW $34.00
  • AVG Volume (30 Days)
  • VCEL 694.4K
  • CXW 1.3M
  • Earning Date
  • VCEL 11-06-2025
  • CXW 11-05-2025
  • Dividend Yield
  • VCEL N/A
  • CXW N/A
  • EPS Growth
  • VCEL 236.54
  • CXW 49.55
  • EPS
  • VCEL 0.25
  • CXW 1.00
  • Revenue
  • VCEL $258,716,999.00
  • CXW $2,086,522,000.00
  • Revenue This Year
  • VCEL $18.35
  • CXW $9.24
  • Revenue Next Year
  • VCEL $22.26
  • CXW $10.69
  • P/E Ratio
  • VCEL $164.69
  • CXW $17.99
  • Revenue Growth
  • VCEL 14.05
  • CXW 5.72
  • 52 Week Low
  • VCEL $29.24
  • CXW $15.95
  • 52 Week High
  • VCEL $63.00
  • CXW $23.85
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 58.46
  • CXW 54.11
  • Support Level
  • VCEL $37.51
  • CXW $15.95
  • Resistance Level
  • VCEL $41.66
  • CXW $17.58
  • Average True Range (ATR)
  • VCEL 1.88
  • CXW 0.62
  • MACD
  • VCEL 0.04
  • CXW 0.17
  • Stochastic Oscillator
  • VCEL 58.37
  • CXW 89.41

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

Share on Social Networks: